- Zonisamide Impurity
-
-
2025-12-16
- CAS:4865-84-3
- Min. Order: 10mg
- Purity: 99%+ HPLC
- Supply Ability: 1000
|
| | 2-(1,2-Benzisoxazol-3-yl)acetic acid Basic information |
| | 2-(1,2-Benzisoxazol-3-yl)acetic acid Chemical Properties |
| Melting point | 123 °C | | Boiling point | 377.3±17.0 °C(Predicted) | | density | 1.394±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | soluble in Methanol | | form | powder to crystal | | pka | 3.60±0.30(Predicted) | | color | White to Light yellow to Light orange | | InChI | InChI=1S/C9H7NO3/c11-9(12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H,11,12) | | InChIKey | BVSIAYQIMUUCRW-UHFFFAOYSA-N | | SMILES | O1C2=C(C=CC=C2)C(CC(O)=O)=N1 | | CAS DataBase Reference | 4865-84-3(CAS DataBase Reference) |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-37/39 | | HazardClass | IRRITANT | | HS Code | 29349990 |
| | 2-(1,2-Benzisoxazol-3-yl)acetic acid Usage And Synthesis |
| Chemical Properties | off-white solid | | Uses | 1,2-Benzisoxazol-3-ylacetic Acid-13C2 is the labeled analogue of 1,2-Benzisoxazol-3-ylacetic Acid. 1,2-Benzisoxazol-3-ylacetic Acid-13C2 is an intermediate in the synthesis of Zonisamide-13C2-15N (Z700003), the labeled analogue of Zonisamide (Z700000), a sulfonamide antiseizure agent; blocks repetitive firing of voltagesensitive sodium channels and reduces voltage-sensitive T-type calcium currents. Heterocyclic methanesulfonide with anticonvulsant properties. The compound is under investigation for potential therapeutic use as an antiepileptic drug. Anticonvulsant. |
| | 2-(1,2-Benzisoxazol-3-yl)acetic acid Preparation Products And Raw materials |
|